Xellera Therapeutics is a CDMO specializing in Cell and Gene Therapies (CGT) and Advanced Therapy Products (ATP), providing comprehensive, GMP-compliant manufacturing services to accelerate the development and commercialization of innovative, next-generation treatments.
